Matchpoint Therapeutics
Acing the future of covalent medicines
Biotechnology Research·0 Followers
Overview
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines initially focused on immunology. For more information, please visit www.matchpoin...See more
Website
https://matchpointtx.com/Industry
Biotechnology Research
Company size
32 employees
Headquarters
Watertown, Mass.
Founded
2021
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$150.0M • Series B
Announced on 10/9/2026
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.